Level Four Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $494K | Sell |
3,061
-88
| -3% | -$14.2K | 0.02% | 524 |
|
|
2025
Q1 | $536K | Buy |
3,149
+280
| +10% | +$47.6K | 0.02% | 484 |
|
|
2024
Q4 | $477K | Buy |
2,869
+101
| +4% | +$16.8K | 0.02% | 504 |
|
|
2024
Q3 | $471K | Sell |
2,768
-432
| -14% | -$73.5K | 0.02% | 524 |
|
|
2024
Q2 | $493K | Sell |
3,200
-116
| -3% | -$17.9K | 0.02% | 491 |
|
|
2024
Q1 | $524K | Hold |
3,316
| – | – | 0.03% | 456 |
|
|
2023
Q4 | $524K | Buy |
+3,316
| New | +$524K | 0.03% | 455 |
|
|
2023
Q3 | – | Sell |
-5,067
| Closed | -$776K | – | 779 |
|
|
2023
Q2 | $776K | Buy |
5,067
+474
| +10% | +$72.6K | 0.05% | 348 |
|
|
2023
Q1 | $712K | Buy |
4,593
+1,953
| +74% | +$303K | 0.05% | 346 |
|
|
2022
Q4 | $407K | Buy |
+2,640
| New | +$407K | 0.03% | 440 |
|
|
2022
Q2 | – | Sell |
-2,132
| Closed | -$318K | – | 588 |
|
|
2022
Q1 | $318K | Buy |
2,132
+53
| +3% | +$7.91K | 0.02% | 503 |
|
|
2021
Q4 | $337K | Buy |
+2,079
| New | +$337K | 0.03% | 495 |
|
|
2021
Q3 | – | Sell |
-3,313
| Closed | -$572K | – | 524 |
|
|
2021
Q2 | $572K | Buy |
+3,313
| New | +$572K | 0.04% | 370 |
|
|
2021
Q1 | – | Sell |
-5,191
| Closed | -$872K | – | 639 |
|
|
2020
Q4 | $872K | Sell |
5,191
-34,825
| -87% | -$5.85M | 0.07% | 271 |
|
|
2020
Q3 | $6.29M | Buy |
40,016
+6,020
| +18% | +$947K | 0.48% | 43 |
|
|
2020
Q2 | $5.71M | Buy |
33,996
+31,205
| +1,118% | +$5.24M | 0.44% | 45 |
|
|
2020
Q1 | $366K | Sell |
2,791
-13
| -0.5% | -$1.71K | 0.04% | 352 |
|
|
2019
Q4 | $418K | Buy |
+2,804
| New | +$418K | 0.02% | 402 |
|
|
2019
Q3 | – | Sell |
-2,574
| Closed | -$363K | – | 513 |
|
|
2019
Q2 | $363K | Buy |
2,574
+108
| +4% | +$15.2K | 0.04% | 381 |
|
|
2019
Q1 | $372K | Buy |
+2,466
| New | +$372K | 0.04% | 362 |
|